[{"NetIncomeLoss_1_Q3_USD":-52704000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":77340896.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":78771930.0,"GainLossOnSaleOfPropertyPlantEquipment_3_Q3_USD":-12000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":27065000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":1094000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-116603000.0,"AssetsCurrent_0_Q3_USD":470012000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":10474613.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":10474613.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":286000.0,"Assets_0_Q3_USD":531588000.0,"ShareBasedCompensation_3_Q3_USD":21620000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":27304000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":3934000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":15834000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":46175000.0,"DepreciationAndAmortization_3_Q3_USD":4367000.0,"MarketableSecuritiesCurrent_0_Q3_USD":376735000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":43819000.0,"ProceedsFromStockPlans_3_Q3_USD":715000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":4367000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":1045000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_3_Q3_USD":952000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_1_Q3_USD":-752000.0,"CommonStockValue_0_Q3_USD":8000.0,"OperatingLeaseImpairmentLoss_3_Q3_USD":238000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":231017000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-137097000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-53456000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":1087000.0,"OtherAssetsNoncurrent_0_Q3_USD":2217000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":84979000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":39257000.0,"Liabilities_0_Q3_USD":221397000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":302590000.0,"CommonStockSharesAuthorized_0_Q3_shares":200000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":16245000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":5904000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":414949000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":-752000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":8030000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-119076000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q3_USD":359300000.0,"LiabilitiesCurrent_0_Q3_USD":71087000.0,"AccountsPayableCurrent_0_Q3_USD":1370000.0,"RestrictedCashNoncurrent_0_Q3_USD":1472000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":86451000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":5699000.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":2098000.0,"AdditionalPaidInCapital_0_Q3_USD":666958000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":337000.0,"ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_1_Q3_USD":1700000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":30583000.0,"NetIncomeLoss_3_Q3_USD":-138049000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":8298000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":112486000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-4662000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-8000.0,"OperatingIncomeLoss_3_Q3_USD":-142416000.0,"OperatingIncomeLoss_1_Q3_USD":-53749000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":26596000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":531588000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":21620000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":8030000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":6736000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-357869000.0,"OperatingExpenses_3_Q3_USD":158661000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.78,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.67,"ProfitLoss_3_Q3_USD":-138049000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":493000.0,"StockholdersEquity_0_Q3_USD":310191000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":110560000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":4244000.0,"OperatingExpenses_1_Q3_USD":59653000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-16245000.0,"Ticker":"ALEC","CIK":"1653087","name":"ALECTOR, INC.","OfficialName":"Alector Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"931151435.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201110"}]